至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

LMNB1 targets FOXD1 to promote progression of prostate cancer

Exp Ther Med. 2023-09; 
Yuanshe Huang, Lai Zhang, Tianlei Liu, E Liang
Products/Services Used Details Operation
Proteins, Expression, Isolation and Analysis … FOXD1), small interfering RNA (siRNA)-LMNB1 and siRNA negative control (NC) were synthesized by Nanjing Genscript Biotechnology Co., Ltd. The sense and antisense strands for … Get A Quote

摘要

Forkhead box D1 (FOXD1) expression is upregulated in various types of human cancer. To the best of our knowledge, the roles of FOXD1 in prostate cancer (PC) remain largely unknown. The Cancer Genome Atlas dataset was used for the bioinformatics analysis of FOXD1 in PC. FOXD1 expression levels in normal immortalized human prostate epithelial cells (RWPE-1) and prostate cancer cells were detected by reverse transcription-quantitative PCR. PC cell viability was detected using Cell Counting Kit-8 assay. Transwell assays were performed to assess the migration and invasion of PC cells. Luciferase reporter gene assay was used to validate the association between FOXD1 and lamin (LMN)B1. LMNB1 is an important part of th... More

关键词

apoptosis, forkhead box D1, lamin B1, prostate cancer, viability